Shanghai Pharma announced that three products from its subsidiary Shangyao Zhonghua — Longhu Cooling Oil Classic, Longhu Cooling Oil Extra Strength, and Longhu Roll-on Essential Oil — received product licences from Health Canada on 30 July 2026. The licences are for the temporary relief of muscle and joint aches or discomfort. The company submitted the registration applications in May 2026, with cumulative registration expenses of approximately 49,500 yuan. Shanghai Pharma stated that this approval is positive for expanding overseas markets, but export business is subject to uncertainties from factors such as overseas regulations, market conditions, and exchange rate fluctuations.
Shanghai Pharmaceuticals Holding Co LtdThree products received Canadian product licences, enabling overseas market expansion.